查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827718

2025年C反应蛋白检测全球市场报告

C-Reactive Protein Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，C反应蛋白检测市场规模稳定成长，从2024年的34.5亿美元增加到2025年的35.2亿美元，复合年增长率为2.0%。预测期内的成长归因于发炎性疾病盛行率的上升、心血管风险评估、人口老化、医疗基础设施的完善以及医疗筛检计画的推进。

预计未来几年C反应蛋白检测市场规模将稳定成长，到2029年将达到42.8亿美元，复合年增长率为5.0%。预测期内的增长可归因于肥胖率上升、个人化医疗和生物标记、远端医疗和远端监控、早期疾病检测以及生活方式相关的发炎。预测期内的主要趋势包括诊断检测、穿戴式健康技术、技术解决方案、策略联盟以及工业4.0的采用。

C反应蛋白 (CRP) 检测是一种诊断程序，用于评估血液中 CRP 的水平。 CRP 是肝臟在发炎反应中产生的蛋白质。当身体受到损伤或感染疾病时，会产生发炎作为防御机制。 CRP 检测主要用于识别感染疾病引起的发炎。

CRP检测市场主要使用的检测法包括酵素结合免疫吸附检测法（ELISA）、化学冷光免疫检测（CLIA）和免疫比浊检测法。例如，ELISA是一种定量测量血清中人体CRP浓度的技术，有助于监测风湿热和发炎等病症。 ELISA是一种专注于测量抗体、抗原、蛋白质和糖蛋白的生物检测法。 CRP检测有助于诊断和监测各种疾病，包括糖尿病、类风湿性关节炎、心血管疾病、发炎性肠道疾病和癌症，广泛应用于临床、医院和诊断实验室。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供 C 反应蛋白检测市场统计数据，例如全球 C 反应蛋白检测行业规模、各地区份额、竞争对手的市场份额、详细的 C 反应蛋白检测细分市场、市场趋势和机会，以及您在 C 反应蛋白检测行业取得成功所需的数据。本 C 反应蛋白检测市场研究报告对该行业的现状和未来情况进行了详细分析，为您提供所需的一切观点。

未来五年5.0%的预测成长率较我们先前对该市场的预测略有下降，下降了0.2%。这一下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自日本和法国等主要地区的乳胶增强免疫检测试剂和发炎标记自动分析仪征收关税直接影响美国，从而导致感染监测能力下降和心血管风险评估成本上升。由于互惠关税以及贸易紧张局势和限制措施加剧对全球经济和贸易的负面影响，这种影响也可能更为广泛。

心血管疾病 (CVD) 盛行率的不断上升预计将推动 C 反应蛋白检测市场的成长。心血管疾病包括血管病变、结构性问题、血栓等心臟疾病。虽然 CVD 的确切病因尚不完全清楚，但有几个因素可能会增加患病风险。其中一个关键因素是由于不良饮食、缺乏运动、吸烟和饮酒导致的行为风险，这些风险会导致动脉中脂肪沉积（动脉粥状硬化），并增加血栓的风险。这些行为风险会导致血压升高、血糖升高、血脂升高、体重增加和肥胖。 CVD 盛行率的不断上升推动了对 C 反应蛋白检测的需求，这种检测与胆固醇检测一样，可以诊断或预测心血管疾病的可能性。例如，卫生指标与评估研究所于2023年12月报告称，2022年全球心血管疾病死亡人数将达到1,980万，而缺血性心臟疾病的死亡率为每10万人108.8人。高收缩压是心血管疾病相关伤残调整生命年（DALY）的主要因素，而饮食风险和空气污染已成为加剧此全球问题的重要行为和环境因素。

临床试验的成长预计将进一步推动C反应蛋白检测市场的发展。临床试验在评估医疗干预措施（包括C反应蛋白检测等诊断程序）的安全性、有效性和潜在益处方面发挥着至关重要的作用。这些临床试验有助于评估C反应蛋白检测在诊断心血管疾病和预测心臟相关疾病风险的准确性和有效性。截至2023年5月，ClinicalTrials.gov已註册452,604项临床试验，其中64,838项正在积极寻找参与者。临床试验的成长证实了C反应蛋白检测日益增长的重要性，并有助于市场扩张。

C反应蛋白检测市场的一个显着趋势是测量设备的技术进步。市场主要企业正优先考虑技术创新，以巩固其市场地位。这些公司正在将下一代C反应蛋白检测技术融入其检测方法中，提供具有最大输出和多种应用等优势的先进解决方案。例如，总部位于芬兰的诊断检测解决方案公司Aidian于2022年2月推出了QuikRead go wrCRP & wrCRP+Hb套件。该套件可在一次运行中从单一检体中提供两种结果—宽范围CRP和Hb。宽范围CRP检测可实现CRP测量，有助于评估新生儿败血症等疾病、预测慢性阻塞性肺病（COPD）的病情严重程度以及评估心血管风险。这项技术进步体现了该公司致力于提供高效、全面的C反应蛋白检测解决方案的承诺。

为了提升市场地位和盈利，C反应蛋白检测市场的主要企业正优先考虑技术创新，推出新的技术疗法，例如C反应蛋白抗原检测。 C反应蛋白（CRP）抗原检测是一种血液检测，旨在测量人体C反应蛋白的水平，C反应蛋白是肝臟对发炎反应所产生的蛋白质。印度医疗技术公司LumiraDx Healthcare Pvt Ltd.于2022年11月推出了C反应蛋白抗原检测。这种微流体免疫测量提供了一种快速且便捷的全血CRP水平测量方法，并描述了一种可供患者附近的医疗保健专业人员使用的自动化体外诊断测试。

2022年6月，美国製药生技公司辉瑞以5.25亿美元收购了ReViral Ltd.。此次收购增强了辉瑞的感染疾病物组合，并强化了其开发抗呼吸道融合细胞病毒（RSV）药物和疫苗的决心。 ReViral Ltd.是一家总部位于英国的生物技术公司，专注于病毒性疾病的创新疗法和CRP检测。

C反应蛋白检测市场的主要企业包括赛默飞世尔科技公司、F Hoffmann-La Roche AG、丹纳赫公司、Quest Diagnostics Incorporated、西门子股份公司、雅培实验室、Aidian Oy、Boditech Med Inc.、堀场製作公司有限公司、Laboratory Corporation、默克公司、Pwan、Sotoin、Soin​​kkone. Biotechs O​​kkkk、B.k. Scientific SE、Inova Diagnostics Inc.、Luminex Corporation、Sekisui Diagnostics LLC、Sysmex Corporation、Tosoh Corporation、Trinity Biotech Plc、WerfenLife Group LLC、ZEUS Scientific Inc.、BioMerieux SA、Biomerica Inc.、Gold Standard Diagnostics Corp.、ImmmedNnoscence Corp.、HadovaNaknos。

2024年，北美是C反应蛋白检测市场最大的地区。预计亚太地区将成为预测期内成长最快的地区。 C反应蛋白检测市场报告涵盖以下地区：亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

C反应蛋白检测市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

C反应蛋白检测市场涵盖营业单位透过仪器和试剂产生的收益。市场规模包括服务供应商销售或包含在其服务产品中的相关商品的价值。仅包括营业单位之间交易或销售给最终消费者的商品和服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球C反应蛋白检测：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球C反应蛋白检测市场：成长率分析
  • 全球C反应蛋白检测市场表现：规模与成长，2019-2024年
  • 全球C反应蛋白检测市场预测：规模与成长，2024-2029年，2034年
  • 全球 C 反应蛋白检测：总潜在市场 (TAM)

第六章 市场细分

  • 全球C反应蛋白检测市场（依检测类型、效能和预测），2019-2024年，2024-2029年，2034年
  • 酵素免疫分析法（ELISA）
  • 化学冷光免疫检测（CLIA）
  • 免疫比浊法
  • 全球C反应蛋白检测市场的应用、效能与预测，2019-2024年、2024-2029年、2034年
  • 糖尿病
  • 类风湿性关节炎
  • 心血管疾病
  • 发炎性肠道疾病
  • 癌症
  • 其他的
  • 全球C反应蛋白检测市场最终用途、绩效及预测（2019-2024年、2024-2029年、2034年）
  • 诊所
  • 医院
  • 诊断实验室
  • 全球 C 反应蛋白检测市场：酵素免疫分析法试验 (ELISA) 细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 直接ELISA
  • 间接ELISA
  • 夹心ELISA
  • 全球 C 反应蛋白检测市场：化学冷光免疫检测(CLIA) 细分、按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 基于光度计的化学发光免疫分析
  • 自动化化学发光免疫分析系统
  • 全球 C 反应蛋白检测市场：免疫检测法细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 免疫比浊检测法
  • 乳胶凝集免疫比浊法

第七章 区域和国家分析

  • 全球C反应蛋白检测市场：依地区、绩效及预测，2019-2024年、2024-2029年、2034年
  • 全球C反应蛋白检测市场（依国家、绩效及预测）2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • C反应蛋白检测市场：竞争格局
  • C反应蛋白检测市场：公司简介
    • Thermo Fisher Scientific Inc.
    • F Hoffmann-La Roche AG
    • Danaher Corporation
    • Quest Diagnostics Incorporated
    • Siemens AG

第31章：其他领先和创新企业

  • Abbott Laboratories
  • Aidian Oy
  • Boditech Med Inc.
  • Horiba Ltd.
  • Laboratory Corporation
  • Merck KGAA
  • Randox Laboratories Limited
  • Getein BIoTech Inc.
  • Bio-Rad Laboratories Inc.
  • DiaSorin SpA
  • Eurofins Scientific SE
  • Inova Diagnostics Inc.
  • Luminex Corporation
  • Sekisui Diagnostics LLC
  • Sysmex Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年C反应蛋白检测市场：提供新机会的国家
  • 2029年C反应蛋白检测市场：细分市场带来新机会
  • C反应蛋白检测市场2029年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r21315u

C-reactive protein (CRP) testing is a diagnostic procedure that assesses the concentration of CRP in the bloodstream, a protein produced by the liver in response to inflammation. In cases of injury or infection, the body initiates inflammation as a protective mechanism. CRP testing is primarily employed to identify inflammation resulting from infections.

The primary assay methods utilized in the CRP testing market include enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and immunoturbidimetric assays. ELISA, for instance, is a technique employed to quantitatively measure human CRP levels in serum, aiding in the monitoring of conditions such as rheumatic fever and inflammatory processes. ELISA serves as a biological assay focusing on the measurement of antibodies, antigens, proteins, and glycoproteins. CRP testing is widely applied in clinical settings, hospitals, and diagnostic laboratories, contributing to the diagnosis and monitoring of various conditions such as diabetes, rheumatoid arthritis, cardiovascular diseases, inflammatory bowel disease, cancer, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The c-reactive protein testing market research report is one of a series of new reports from The Business Research Company that provides c-reactive protein testing market statistics, including c-reactive protein testing industry global market size, regional shares, competitors with an c-reactive protein testing market share, detailed c-reactive protein testing market segments, market trends and opportunities, and any further data you may need to thrive in the c-reactive protein testing industry. This c-reactive protein testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The c-reactive protein testing market size has grown steadily in recent years. It will grow from $3.45 billion in 2024 to $3.52 billion in 2025 at a compound annual growth rate (CAGR) of 2.0%. The growth in the historic period can be attributed to increased inflammatory disease prevalence, cardiovascular risk assessment, increased aging population, increased healthcare infrastructure, and healthcare screening programs.

The c-reactive protein testing market size is expected to see steady growth in the next few years. It will grow to $4.28 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to rising obesity rates, personalized medicine and biomarkers, telehealth and remote monitoring, early disease detection, and lifestyle-related inflammation. Major trends in the forecast period include diagnostic testing advancements, wearable health technology, technological solutions, strategic collaborations, and industry 4.0 introduction.

The forecast of 5.0% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on latex-enhanced immunoassay reagents and automated inflammation marker analyzers, sourced from key regions such as Japan and France, which could lead to reduced capacity for infection monitoring and higher costs for cardiovascular risk assessment.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rise in cardiovascular disease (CVD) cases is expected to drive the growth of the C-reactive protein testing market. Cardiovascular diseases encompass heart conditions such as diseased vessels, structural issues, and blood clots. While the exact cause of CVD is not fully understood, several factors can increase the risk of developing it. One significant factor is behavioral risk, stemming from poor diet, insufficient physical activity, smoking, and alcohol consumption, which leads to the buildup of fatty deposits in the arteries (atherosclerosis) and heightens the risk of blood clots. These behavioral risks contribute to elevated blood pressure, glucose levels, blood lipids, weight gain, and obesity. As CVD cases rise, there is an increasing demand for C-reactive protein testing to diagnose or predict the likelihood of cardiovascular issues, similar to cholesterol testing. For example, in December 2023, the Institute for Health Metrics and Evaluation reported that global deaths from cardiovascular diseases reached 19.8 million in 2022, with ischemic heart disease accounting for 108.8 deaths per 100,000 people. High systolic blood pressure was the leading contributor to disability-adjusted life years (DALYs) associated with CVD, while dietary risks and air pollution emerged as significant behavioral and environmental factors exacerbating this global issue.

The increasing number of clinical trials is anticipated to further boost the c-reactive protein testing market. Clinical trials play a crucial role in assessing the safety, efficacy, and potential benefits of medical interventions, including diagnostic procedures like c-reactive protein testing. These trials are instrumental in evaluating the accuracy and efficacy of CRP testing in diagnosing cardiovascular diseases and predicting the risk of heart-related conditions. As of May 2023, there are 452,604 clinical studies registered on ClinicalTrials.gov, with 64,838 actively seeking participants, marking a notable increase from early 2021. This rise in clinical trials underscores the growing importance of c-reactive protein testing, contributing to the market's expansion.

A noteworthy trend in the c-reactive protein testing market is the technological advancement in measuring devices. Key players in the market are prioritizing technological innovation to strengthen their market positions. These companies are integrating next-generation c-reactive testing technologies into their methods, providing advanced solutions with benefits like maximum output and multiple usages. For example, Aidian, a Finnish-based diagnostic tests and solutions company, introduced the QuikRead go wrCRP & wrCRP+Hb kits in February 2022. This kit delivers two results, a wide range of CRP and Hb, from a single sample with one analysis. The wide-range CRP test allows for CRP readings that assess conditions like neonatal sepsis, predict disease severity in COPD, and aid in cardiovascular risk assessment. This technological advancement reflects a commitment to offering efficient and comprehensive c-reactive protein testing solutions.

Key players in the c-reactive protein testing market are prioritizing innovation by introducing new technological treatments, such as the C-Reactive Protein antigen test, to enhance their market standing and profitability. The C-Reactive Protein (CRP) antigen test is a blood test designed to measure the body's level of C-Reactive Protein, a protein produced by the liver in response to inflammation. LumiraDx Healthcare Pvt Ltd., an India-based medical technology company, launched the C-Reactive Protein antigen test in November 2022. This microfluidic immunoassay offers a quick and simple way to measure CRP levels in whole blood, providing an automated in vitro diagnostic test for healthcare professionals to use in close proximity to patients.

In June 2022, Pfizer Inc., a US-based pharmaceutical and biotechnology company, acquired ReViral Ltd. for $525 million. This acquisition enhances Pfizer's anti-infective portfolio and reinforces its commitment to developing medicines and vaccines to combat respiratory syncytial virus (RSV). ReViral Ltd. is a UK-based biotech company that specializes in innovative therapies for viral diseases and C-reactive protein (CRP) testing.

Major companies operating in the c-reactive protein testing market include Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMerieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation

North America was the largest region in the c-reactive protein testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the c-reactive protein testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the c-reactive protein testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The c-reactive protein testing market includes revenues earned by entities by devices and reagents. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

C-Reactive Protein Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on c-reactive protein testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for c-reactive protein testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The c-reactive protein testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA); Chemiluminescence Immunoassay (CLIA); Immunoturbidimetric Assays
  • 2) By Application: Diabetes; Rheumatoid Arthritis; Cardiovascular Disease; Inflammatory Bowel Disease; Cancer; Other Applications
  • 3) By End Use: Clinics; Hospitals; Diagnostic Laboratories
  • Subsegments:
  • 1) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA; Indirect ELISA; Sandwich ELISA
  • 2) By Chemiluminescence Immunoassay (CLIA): Luminometer-Based CLIA; Automated CLIA Systems
  • 3) By Immunoturbidimetric Assays: Nephelometry-Based Immunoturbidimetric Assays; Latex Agglutination Immunoturbidimetric Assays
  • Companies Mentioned: Thermo Fisher Scientific Inc.; F Hoffmann-La Roche AG; Danaher Corporation; Quest Diagnostics Incorporated; Siemens AG; Abbott Laboratories; Aidian Oy; Boditech Med Inc.; Horiba Ltd.; Laboratory Corporation; Merck KGAA; Randox Laboratories Limited; Getein Biotech Inc.; Bio-Rad Laboratories Inc.; DiaSorin S.p.A.; Eurofins Scientific SE; Inova Diagnostics Inc.; Luminex Corporation; Sekisui Diagnostics LLC; Sysmex Corporation; Tosoh Corporation; Trinity Biotech Plc; WerfenLife Group LLC; ZEUS Scientific Inc.; BioMerieux SA; Biomerica Inc.; Gold Standard Diagnostics Corp.; Immunodiagnostic Systems Holdings PLC; Nova Biomedical Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. C-Reactive Protein Testing Market Characteristics

3. C-Reactive Protein Testing Market Trends And Strategies

4. C-Reactive Protein Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global C-Reactive Protein Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global C-Reactive Protein Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global C-Reactive Protein Testing Market Growth Rate Analysis
  • 5.4. Global C-Reactive Protein Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global C-Reactive Protein Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global C-Reactive Protein Testing Total Addressable Market (TAM)

6. C-Reactive Protein Testing Market Segmentation

  • 6.1. Global C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Chemiluminescence Immunoassay (CLIA)
  • Immunoturbidimetric Assays
  • 6.2. Global C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diabetes
  • Rheumatoid Arthritis
  • Cardiovascular Disease
  • Inflammatory Bowel Disease
  • Cancer
  • Other Applications
  • 6.3. Global C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinics
  • Hospitals
  • Diagnostic Laboratories
  • 6.4. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Enzyme-Linked Immunosorbent Assay (ELISA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct ELISA
  • Indirect ELISA
  • Sandwich ELISA
  • 6.5. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Chemiluminescence Immunoassay (CLIA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Luminometer-Based CLIA
  • Automated CLIA Systems
  • 6.6. Global C-Reactive Protein Testing Market, Sub-Segmentation Of Immunoturbidimetric Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nephelometry-Based Immunoturbidimetric Assays
  • Latex Agglutination Immunoturbidimetric Assays

7. C-Reactive Protein Testing Market Regional And Country Analysis

  • 7.1. Global C-Reactive Protein Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global C-Reactive Protein Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific C-Reactive Protein Testing Market

  • 8.1. Asia-Pacific C-Reactive Protein Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China C-Reactive Protein Testing Market

  • 9.1. China C-Reactive Protein Testing Market Overview
  • 9.2. China C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India C-Reactive Protein Testing Market

  • 10.1. India C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan C-Reactive Protein Testing Market

  • 11.1. Japan C-Reactive Protein Testing Market Overview
  • 11.2. Japan C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia C-Reactive Protein Testing Market

  • 12.1. Australia C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia C-Reactive Protein Testing Market

  • 13.1. Indonesia C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea C-Reactive Protein Testing Market

  • 14.1. South Korea C-Reactive Protein Testing Market Overview
  • 14.2. South Korea C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe C-Reactive Protein Testing Market

  • 15.1. Western Europe C-Reactive Protein Testing Market Overview
  • 15.2. Western Europe C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK C-Reactive Protein Testing Market

  • 16.1. UK C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany C-Reactive Protein Testing Market

  • 17.1. Germany C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France C-Reactive Protein Testing Market

  • 18.1. France C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy C-Reactive Protein Testing Market

  • 19.1. Italy C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain C-Reactive Protein Testing Market

  • 20.1. Spain C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe C-Reactive Protein Testing Market

  • 21.1. Eastern Europe C-Reactive Protein Testing Market Overview
  • 21.2. Eastern Europe C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia C-Reactive Protein Testing Market

  • 22.1. Russia C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America C-Reactive Protein Testing Market

  • 23.1. North America C-Reactive Protein Testing Market Overview
  • 23.2. North America C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA C-Reactive Protein Testing Market

  • 24.1. USA C-Reactive Protein Testing Market Overview
  • 24.2. USA C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada C-Reactive Protein Testing Market

  • 25.1. Canada C-Reactive Protein Testing Market Overview
  • 25.2. Canada C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America C-Reactive Protein Testing Market

  • 26.1. South America C-Reactive Protein Testing Market Overview
  • 26.2. South America C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil C-Reactive Protein Testing Market

  • 27.1. Brazil C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East C-Reactive Protein Testing Market

  • 28.1. Middle East C-Reactive Protein Testing Market Overview
  • 28.2. Middle East C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa C-Reactive Protein Testing Market

  • 29.1. Africa C-Reactive Protein Testing Market Overview
  • 29.2. Africa C-Reactive Protein Testing Market, Segmentation By Assay Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa C-Reactive Protein Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa C-Reactive Protein Testing Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. C-Reactive Protein Testing Market Competitive Landscape And Company Profiles

  • 30.1. C-Reactive Protein Testing Market Competitive Landscape
  • 30.2. C-Reactive Protein Testing Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens AG Overview, Products and Services, Strategy and Financial Analysis

31. C-Reactive Protein Testing Market Other Major And Innovative Companies

  • 31.1. Abbott Laboratories
  • 31.2. Aidian Oy
  • 31.3. Boditech Med Inc.
  • 31.4. Horiba Ltd.
  • 31.5. Laboratory Corporation
  • 31.6. Merck KGAA
  • 31.7. Randox Laboratories Limited
  • 31.8. Getein Biotech Inc.
  • 31.9. Bio-Rad Laboratories Inc.
  • 31.10. DiaSorin S.p.A.
  • 31.11. Eurofins Scientific SE
  • 31.12. Inova Diagnostics Inc.
  • 31.13. Luminex Corporation
  • 31.14. Sekisui Diagnostics LLC
  • 31.15. Sysmex Corporation

32. Global C-Reactive Protein Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The C-Reactive Protein Testing Market

34. Recent Developments In The C-Reactive Protein Testing Market

35. C-Reactive Protein Testing Market High Potential Countries, Segments and Strategies

  • 35.1 C-Reactive Protein Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 C-Reactive Protein Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 C-Reactive Protein Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer